GNMSF vs MSFT: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Microsoft Corp in 2026
GNMSF
Genmab A/S
$290.00
MSFT
Microsoft Corp
$408.40
Key Metrics Comparison
| Metric | GNMSF | MSFT | Winner |
|---|---|---|---|
| Market Cap | $17.86B | N/A | GNMSF |
| P/E Ratio | 18.87 | 36.30 | GNMSF |
| EPS (TTM) | $15.37 | $13.70 | GNMSF |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 93.6% | 68.8% | GNMSF |
Analyze GNMSF
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or MSFT a better investment?
Comparing GNMSF and MSFT: Genmab A/S has a market cap of $17.86B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and MSFT?
GNMSF (Genmab A/S) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or MSFT?
Based on P/E ratios, GNMSF trades at a lower multiple (18.9x vs 36.3x).
Which is growing faster: GNMSF or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for GNMSF.
Which company is more profitable: GNMSF or MSFT?
Genmab A/S (GNMSF) has higher gross margins at 93.6% compared to 68.8% for MSFT.
Which is the larger company: GNMSF or MSFT?
Genmab A/S (GNMSF) is larger with a market cap of $17.86B compared to N/A for MSFT.
Should I buy GNMSF or MSFT in 2026?
Both GNMSF and MSFT have investment merit. GNMSF trades at $290.00 while MSFT trades at $408.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and MSFT stock?
Key differences: Market Cap ($17.86B vs N/A), P/E Ratio (18.9x vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (93.6% vs 68.8%).